Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China. (15th January 2021)

• Record Type: Journal Article
• Authors: Peng, Yong; Du, Xin; Li, Xian; Ji, Jiachao; Wu, Yangfeng; Gao, Runlin; Patel, Anushka
• Is Part Of: International journal of cardiology. Volume 323(2021)
• Page Start: 7
• Page End: 12
• Publication Date: 2021-01-15
• Subjects: Acute coronary syndrome -- Key performance indicators -- Renal insufficiency -- Clinical pathways; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2020.08.022
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: We aimed to analyze the association of estimated glomerular filtration rate (eGFR) levels of hospitalized patients with treatment decisions and clinical outcomes in Chinese patients with acute coronary syndrome (ACS). Methods: This was a secondary analysis study from CPACS-2 Program which was a trial of a quality improvement intervention in China and recruited 15, 141 patients from 75 hospitals between October 2007 and August 2010. All patients were divided into three groups by the eGFR level on admission. The primary outcomes were several key performance indicators (KPIs) reflecting the management of ACS and the secondary outcomes were clinical outcomes. Results: A total of 14, 437 ACS patients were enrolled in this analysis. Among patients with reduced eGFR levels, fewer patients received appropriate medical therapy ( p for trend <0.001) and fewer high-risk patients received coronary angiography ( p for trend <0.001) compared to patients with a normal eGFR. Furthermore, 436 cases of death, 357 cases of cardiac death, 686 cases of major adverse cardiovascular events, and 198 cases of major bleeding episodes were reported. Patients with a worse eGFR level had significantly higher rates of death ( p for trend <0.001), cardiac death ( p for trend <0.001), major adverse cardiovascular events ( p for trend <0.001) and major bleeding episodes ( p for trend <0.001). Conclusion: Among Chinese ACS patients, those with renal insufficiency have a lower percentage of adherence to guideline-recommended treatments and worse clinical prognosis. Renal insufficiency is an important factor affecting guideline implementation in Chinese ACS patients. Clinical trial registration: http://www.anzctr.org.au/default.aspx . Unique identifier: ACTRN12609000491268. Highlights: In reduced eGFR levels more patients had a longer length of hospitalization stay. In reduced eGFR levels less patients received appropriate medical therapy. In reduced eGFR levels and less high-risk patients received coronary angiography. Patients with worse eGFR level had significant worse clinical outcomes. Renal insufficiency is important to guideline implementation in ACS in China.